NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation

Gang Wu(Huazhong University of Science and Technology), Sheng Zhang(Fujian Medical University)
OncoTargets and Therapy
January 1, 2015
Cited by 26


Related Papers